IDEAYA Biosciences (IDYA) Enterprise Value
Price: $18.63
Market Cap: $1.63B
Avg Volume: 1.17M
Market Cap: $1.63B
Avg Volume: 1.17M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to IDEAYA Biosciences's latest quarterly financial reports:
- The enterprise value (EV) is 2.03B, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 2.10B, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $25.7, with 81.68M shares outstanding.
- The company has 84.38M in cash and cash equivalents and 19.17M in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$2.03B
Market Cap
$2.10B
Total Debt
$19.17M
Cash and Equivalents
$84.38M
Historical Enterprise Value
IDEAYA Biosciences Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.
| Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | $2.03B | -13.41% | $25.7 | 81.68M | $2.10B | $84.38M | $19.17M |
| September 30, 2024 | $2.35B | -10.32% | $31.68 | 86.19M | $2.73B | $400.28M | $18.80M |
| June 30, 2024 | $2.62B | -15.17% | $35.92 | 77.96M | $2.80B | $183.05M | $1.87M |
| March 31, 2024 | $3.09B | 42.47% | $42.52 | 75.11M | $3.19B | $108.34M | $2.41M |
| December 31, 2023 | $2.17B | 47.53% | $35.58 | 65.25M | $2.32B | $157.02M | $2.87M |
| September 30, 2023 | $1.47B | 20.25% | $26.98 | 60.00M | $1.62B | $151.85M | $2.10M |
| June 30, 2023 | $1.22B | 103.63% | $23.5 | 56.25M | $1.32B | $102.84M | $2.57M |
| March 31, 2023 | $599.92M | -25.88% | $13.73 | 48.37M | $664.12M | $67.24M | $3.03M |
| December 31, 2022 | $809.41M | 60.83% | $18.17 | 48.13M | $874.56M | $68.63M | $3.48M |
| September 30, 2022 | $503.27M | 2.97% | $14.92 | 40.30M | $601.30M | $101.95M | $3.92M |
| June 30, 2022 | $488.77M | 28.18% | $13.8 | 38.66M | $533.52M | $49.11M | $4.36M |
| March 31, 2022 | $381.33M | -53.49% | $11.19 | 38.59M | $431.84M | $55.29M | $4.77M |
| December 31, 2021 | $819.87M | -3.49% | $23.64 | 38.36M | $906.74M | $92.05M | $5.18M |
| September 30, 2021 | $849.50M | 40.37% | $25.49 | 37.36M | $952.34M | $108.43M | $5.58M |
| June 30, 2021 | $605.17M | -1.76% | $20.99 | 32.85M | $689.62M | $90.43M | $5.97M |
| March 31, 2021 | $615.99M | 79.71% | $23.5 | 31.76M | $746.39M | $136.75M | $6.35M |
| December 31, 2020 | $342.77M | 21.33% | $14 | 29.15M | $408.09M | $72.04M | $6.72M |
| September 30, 2020 | $282.51M | 79.82% | $12.56 | 28.40M | $356.66M | $81.24M | $7.09M |
| June 30, 2020 | $157.11M | 188.44% | $14.21 | 21.00M | $298.43M | $147.54M | $6.22M |
| March 31, 2020 | $54.47M | -56.19% | $4.12 | 20.25M | $83.43M | $35.46M | $6.50M |
| December 31, 2019 | $124.33M | -16.90% | $7.5 | 20.22M | $151.62M | $34.07M | $6.77M |
| September 30, 2019 | $149.62M | 36.53% | $9 | 20.16M | $181.42M | $38.85M | $7.04M |
| June 30, 2019 | $109.59M | -42.45% | $9.6 | 19.82M | $190.26M | $88.11M | $7.44M |
| March 31, 2019 | $190.41M | 37.13% | $11.19 | 19.48M | $217.97M | $35.30M | $7.74M |
| December 31, 2018 | $138.85M | -12.87% | $11.19 | 14.24M | $159.36M | $20.50M | $- |
| September 30, 2018 | $159.36M | 0.00% | $11.19 | 14.24M | $159.36M | $- | $- |
| June 30, 2018 | $159.36M | -7.63% | $11.19 | 14.24M | $159.36M | $- | $- |
| March 31, 2018 | $172.51M | - | $11.19 | 14.24M | $159.36M | $-13.16M | $- |
Related Metrics
Explore detailed financial metrics and analysis for IDYA.